StonvexLoading…
StonvexStonvexStonvexCore line items from CHH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $1.54B | $1.40B | $1.07B | $772.60M |
Operating Income | $375.03M | $478.60M | $428.93M | $121.67M |
Net Income | $258.51M | $332.15M | $288.96M | $75.39M |
EPS (Diluted) | $5.07 | $5.99 | $5.15 | $1.35 |
Total Assets | $2.39B | $2.10B | $1.93B | $1.59B |
Total Liabilities | $2.36B | $1.95B | $1.67B | $1.59B |
Cash & Equivalents | $26.75M | $41.57M | $511.61M | $234.78M |
Free Cash Flow OCF − CapEx | $227.99M | $301.25M | Not available | Not available |
Shares Outstanding | 49.53M | 52.20M | 55.61M | 55.54M |